Low-dose granulocyte colony-stimulating factor (G-CSF) was used in 2 of 10 patients with severe neutropenia and resulted in the prompt improvement of the absolute neutrophil count [7,9], though its long-term efficacy and safety in terms of clonal evolution remains unclear. The gene discussed is CSF3; the disease is neutropenia.